FDA authorizes second COVID antiviral pill, if no alternative available

The White House expects millions of courses of the drug from Merck and Ridgeback Biotherapeutics by the end of January.

Share this:

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Ohio GOP governor signs abortion bill into law

Republicans’ Confidence Rebounds In December As Inflation Fears Ease